Major drug companies agree to price negotiations with US government
Oct 03, 2023
Ten drugs have been chosen for price negotiations by the Centers for Medicare & Medicaid Services.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
AHA: Fresh produce prescription improves glycemic control
Nov 14, 2023
The findings were seen among low-income individuals with diabetes and poor glycemic control.
Diabetes increases risk for functional limitations in older adults
May 03, 2024
The findings were seen even after controlling for sociodemographic and other health factors.
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
Fresh, delivered produce tied to improvements in CVD risk factors
Mar 22, 2024
Significant improvements were seen for produce consumption, physical activity, non-high-density lipoprotein cholesterol and HbA1c.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Burden of heart disease considerable for American Indians, Alaska Natives
Sep 26, 2023
Half of the participants reported at least one severe cardiovascular condition; the overall mortality rate was 19.8%.